Cargando…
Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
Autores principales: | Lin, Yu-Chin, Wu, Meng-Hsuan, Wei, Tzu-Tang, Lin, Yun-Chieh, Huang, Wen-Chih, Huang, Liang-Yu, Lin, Yi-Ting, Chen, Ching-Chow |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779279/ https://www.ncbi.nlm.nih.gov/pubmed/31620247 http://dx.doi.org/10.18632/oncotarget.27228 |
Ejemplares similares
-
Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
por: Lin, Yu-Chin, et al.
Publicado: (2014) -
Correction: Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
por: Lin, Yu-Chin, et al.
Publicado: (2019) -
Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia 14 (2012) 463–475]
por: Lin, Yu-Chin, et al.
Publicado: (2017) -
Adenine Combined with Cisplatin Promotes Anticancer Activity against Hepatocellular Cancer Cells through AMPK-Mediated p53/p21 and p38 MAPK Cascades
por: Huang, Jhen-Yu, et al.
Publicado: (2022) -
Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
por: Hu, Qinchao, et al.
Publicado: (2020)